ADX48621

DRUG2 trials

Sponsors

Addex Pharma S.A., Johns Hopkins University

Conditions

HealthyParkinson's Disease

Phase 1

PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration

CompletedNCT02447640

Johns Hopkins UniversityHealthy

Start: 2015-04-30End: 2017-12-31Updated: 2018-08-17

Phase 2

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

CompletedNCT01336088

Addex Pharma S.A.Parkinson's Disease

Start: 2011-04-30End: 2012-02-29Updated: 2012-07-16